PortfoliosLab logo

Antares Pharma, Inc. (ATRS)

Equity · Currency in USD · Last updated Jun 25, 2022

Company Info

ISINUS0366421065
CUSIP036642106
SectorHealthcare
IndustryMedical Instruments & Supplies

Trading Data

Previous Close$5.59
Year Range$3.15 - $5.59
EMA (50)$5.02
EMA (200)$4.25
Average Volume$5.75M
Market Capitalization$955.06M

ATRSShare Price Chart


Chart placeholderClick Calculate to get results

ATRSPerformance

The chart shows the growth of $10,000 invested in Antares Pharma, Inc. on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $47,778 for a total return of roughly 377.78%. All prices are adjusted for splits and dividends.


ATRS (Antares Pharma, Inc.)
Benchmark (^GSPC)

ATRSReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M0.36%-7.73%
YTD56.58%-17.30%
6M63.45%-15.83%
1Y37.01%-5.16%
5Y17.01%10.40%
10Y6.84%11.54%

ATRSMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

ATRSSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Antares Pharma, Inc. Sharpe ratio is 0.66. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


ATRS (Antares Pharma, Inc.)
Benchmark (^GSPC)

ATRSDividend History


Antares Pharma, Inc. doesn't pay dividends

ATRSDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


ATRS (Antares Pharma, Inc.)
Benchmark (^GSPC)

ATRSWorst Drawdowns

The table below shows the maximum drawdowns of the Antares Pharma, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Antares Pharma, Inc. is 86.73%, recorded on Mar 16, 2016. It took 1531 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-86.73%Jul 23, 2012917Mar 16, 20161531Apr 13, 20222448
-40.78%Dec 6, 20118Dec 15, 201156Mar 8, 201264
-29.96%Jul 25, 201111Aug 8, 201172Nov 17, 201183
-29.23%Jun 28, 201061Sep 22, 2010180Jun 9, 2011241
-18.07%Mar 27, 201246May 31, 201212Jun 18, 201258
-12.6%Jan 12, 201017Feb 4, 201011Feb 22, 201028
-12.43%May 18, 20106May 25, 20109Jun 8, 201015
-10.26%Jun 21, 20102Jun 22, 20103Jun 25, 20105
-9.87%Mar 24, 20104Mar 29, 20103Apr 1, 20107
-8.93%Apr 9, 201018May 4, 20106May 12, 201024

ATRSVolatility Chart

Current Antares Pharma, Inc. volatility is 1.42%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


ATRS (Antares Pharma, Inc.)
Benchmark (^GSPC)

Portfolios with Antares Pharma, Inc.


Loading data...